![]() |
市場調査レポート
商品コード
1517285
2ピースエンプティハードカプセルの世界市場:原料 (ゼラチン・ヒドロキシプロピルメチルセルロース・デンプン・プルラン)・サイズ・エンドユーザー・地域別の予測 (~2032年)Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose, Starch and Pullulan), By size, By End Users And by Region - Forecast Till 2032 |
||||||
|
2ピースエンプティハードカプセルの世界市場:原料 (ゼラチン・ヒドロキシプロピルメチルセルロース・デンプン・プルラン)・サイズ・エンドユーザー・地域別の予測 (~2032年) |
出版日: 2024年06月25日
発行: Market Research Future
ページ情報: 英文 121 Pages
納期: 即納可能
![]() |
2ピースエンプティハードカプセルの市場規模は、2023年の11億3,000万米ドル、2024年の12億米ドルから、予測期間中は7.08%のCAGRで推移し、2032年には22億3,000万米ドルの規模に成長すると予測されています。
2ピースエンプティハードカプセル市場は、主に非感染性疾患 (NCD) の罹患率の上昇によって急速に拡大しています。世界保健機関 (WHO) は、2023年にはNCDにより年間4,100万人が死亡し、世界全体の死因の74%を占めたと推計しています。世界で肥満、糖尿病、心血管疾患などの疾病の有病率が上昇し、医薬品や栄養補助食品の使用が増加した結果、エンプティハードカプセルの需要が増加しています。
カプセルは飲み込みやすく、医薬品の味を隠すことができるため、患者の服薬コンプライアンス、特に長期的な治療計画の面でもメリットがあります。これは、患者中心の医薬品開発手法という大きな業界動向によく合致しています。
地域的展望
北米地域は2022年に36.60%で最大のシェアを示し、予測期間中はCAGR 5.70%で成長し、2032年には7億1,000万米ドルを超える規模に達すると予想されています。一方、アジア太平洋は同期間中に8.89%でもっとも高いCAGRで成長すると予測されています。
北米の2ピース空ハードカプセル市場は、着実な成長が予測され、良い未来が待っています。ヘルスケアインフラへの投資や現代医療に対する一般市民の意識の高まりから、市場のさらなる拡大が予想されます。
当レポートでは、世界の2ピースエンプティハードカプセルの市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose (HPMC), Starch and Pullulan), By size (Size "00" capsules, Size "0" capsules, Size "1" capsules, Size "2" capsules, others), By End Users (Pharmaceutical Companies, Health & Nutrition, Others) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) - Forecast Till 2032
The size of the two-piece empty hard capsule market was estimated at USD 1.13 billion in 2023 and is expected to increase at a compound yearly growth rate (CAGR) of 7.08% from USD 1.20 billion in 2024 to USD 2.23 billion by 2032.
The market for two-piece empty hard capsules is expanding rapidly, driven mostly by the rising incidence of non-communicable diseases (NCDs). The World Health Organization (WHO) estimates that noncommunicable diseases (NCDs) would kill 41 million people year in 2023, making up 74% of all deaths globally. The demand for empty hard capsules has increased as a result of the increased use of pharmaceutical and nutraceutical therapies due to the rising prevalence of disorders including obesity, diabetes, and cardiovascular diseases around the world. These capsules are effective drug delivery systems that make it easier to provide different formulations to treat the complicated issues related to non-communicable diseases. Pharmaceutical companies are using two-piece empty hard capsules to encapsulate a wide range of medicinal substances, taking advantage of their adaptability as healthcare systems worldwide attempt to control and cure these common chronic illnesses.
Because the capsules are easy to swallow and hide the taste of pharmaceuticals, they also have a benefit in terms of patient compliance, particularly in long-term treatment regimes. This fits well with the larger industry trend of drug development methodologies that are patient centric.
Insights on Market Segments
Based on raw material, the global Two-Piece Empty Hard capsule segmentation comprises pullulan, gelatin, hydroxypropyl methylcellulose (HPMC), and starch.
Size-based market segmentation for two-piece empty hard capsules comprises of capsules with a "00" size, "0" size, "1" size, "2" size, and other sizes.
The end-user segmentation of the two-piece empty hard capsule market includes pharmaceutical businesses, health and nutrition, and other categories.
RegionalPerspectives
With the biggest market share of 36.60% in 2022, the North American two-piece empty hard capsule market is expected to grow at a 5.70% CAGR to reach over USD 0.71 billion by 2032. Nonetheless, throughout the course of the projection period, Asia-Pacific is expected to develop at the highest CAGR of 8.89%.
The two-piece empty hard capsule market in North America has a good future ahead of it, with steady growth predicted. Further market expansion is anticipated because of investments in healthcare infrastructure and rising public awareness of modern medical treatments.
Due to rising healthcare costs, the prevalence of chronic diseases, and technological improvements, the Europe Two-Piece Empty Hard Capsule Market had the second-largest market share.
The market for two-piece empty hard capsules in the Asia-Pacific region is anticipated to develop at the quickest rate between 2024 and 2032 due to the region's high patient population, rise in chronic illnesses, and advantageous regulatory framework. The expansion of major companies in the Two-Piece Empty Hard Capsule Market into this area is also propelling the growth of the regional market.
Principal Players
Important Businesses CapsCanada (Canada), Roxlor (US), Goerlich Pharma GmbH (Europe), Lonza (Switzerland), Qualicaps (US), Suheung (South Korea), ACG (India), Hunan Er-Kang Pharmaceutical Co. Ltd (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), and Bright Pharma Caps (US) are some of the companies that sell two-piece empty hard capsules on the market.